Healthcare - Biotechnology - NASDAQ - US
$ 3.47
-12.2 %
$ 247 M
Market Cap
-1.31
P/E
Price Target
Average
245.82%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
26.61%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Zentalis Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for ZNTL of $12 , with forecasts ranging from a low of $4 to a high of $32 .
ZNTL Lowest Price Target
Wall Street Target
4 USD
15.27%
ZNTL Average Price Target
Wall Street Target
12 USD
245.82%
ZNTL Highest Price Target
Wall Street Target
32 USD
822.19%
REVENUE FORECAST
Revenue Forecast Chart ZNTL
EBIT FORECAST
EBIT Forecast Chart ZNTL
NET INCOME FORECAST
Net Income Chart ZNTL